New answer by Radiation Oncologist at Vanderbilt-Ingram Cancer Center (January 11, 2024)
In the absence of data in this space, no. The improvements observed in ES-SCLC in IMpower133 and CASPIAN with the addition of ICI were modest at best. Pending results from ADR...